Replies to post #276 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

MNTA Insider Shareholdings

[Updated for 2/27/09 SEC filings for issuances of restricted
stock and options to executive officers. CEO Wheeler now has
a 10b5-1 plan, which I regard as modestly bearish; on the other
hand, Wheeler’s sale this week was his first ever and it was only
0.1% of his aggregate holding including options. All told, Wheeler
now owns about 2.5% of MNTA’s overall equity (#msg-35947046).]

 
 Executive Officers  
 *Craig Wheeler, CEO        417K shares   575K options 
 G. Venkataraman, SVP R&D   465K shares   163K options 
 Steven Brugger, COO        280K shares   186K options 
 *John Bishop, SVP Pharma    46K shares   186K options 
 †Bruce Leicher, Gen Counsel 32K shares   113K options 
 ‡James Roach, CMO           10K shares   182K options 
 *Richard Shea, CFO          34K shares   225K options 
 -- 
 6 executive officers     1,284K shares 1,630K options

 
 Non-executive directors  
 John Clarke                 77K shares    96K options 
 Alan Crane (Polaris)       579K shares    74K options 
 Marsha Fanucci                0 shares    96K options 
 Peter Hutt                  67K shares   176K options 
 Robert Langer              950K shares    96K options 
 *Ram Sasisekharan          406K shares    96K options 
 *Bennett Shapiro             7K shares   114K options 
 Elizabeth Stoner              0 shares    49K options 
 **James Sulat                 0 shares    30K options 
 -- 
 9 non-executive dirctrs  2,086K shares   827K options

 
 All officers/directors   3,370K shares 2,457K options 
  
 *10b5-1 selling plan in effect. 
 **Joined BoD 6/5/08. 
 †Hired 7/24/08. 
 ‡Hired 2/26/08.